Using a myeloid-specific BRD4-knockout mouse model (Brd4fl/fl LysM-Cre), myeloid lineage loss of BRD4 decreased splenic and tumor MDSCs in the Lewis lung carcinoma (LLC) model. Here, BRD4 is linked to neoplasm.